Related Experiment Video
Updated: Aug 8, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Central retinal artery occlusion in a patient with sickle cell disease treated with recombinant tissue plasminogen
Slaven Pikija1, Marieta V Peycheva2, Rousan Aghayan-Ugurluoglu1
1Paracelsus Medical University, Salzburg, Austria.
Abstract:
Central retinal artery occlusion is a rare ophthalmological complication of sickle cell disease, usually provoked by additional contributing risk factors and its treatment remains controversial. We describe a patient with sickle cell disease and a spontaneous central retinal artery occlusion of his left eye that probably has good result from intravenous thrombolysis. We want to add sickle cell disease as rare etiological cause of central retinal artery occlusion and perpetuate evidence of intravenous recombinant tissue plasminogen activator administration in this condition.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
iPS Cell Differentiation

